Category: Health
BF.7: Another contender for global domination
The XBB and BQ.1 variants have recently been making headlines, but another SARS-CoV-2 variant, BF.7 has been closely tracking their success across the globe. More...
Preprint: Neutralizing antibody escape of BQ.1, BQ.1.1, BA.4.6, BF.7 and BA.2.75.2
A recent preprint looks at the neutralizing antibody escape abilities for several new variants causing concern across the globe. More...
US Senate committee reports on the origins of the COVID-19 pandemic
“Substantial evidence suggests that the COVID-19 pandemic was the result of a research-related incident associated with a laboratory in Wuhan, China.” More...
Hospitalized Covid-19 patients have 118 times greater risk of death than outpatients
Hospitalized COVID-19 patients were at dramatically higher risk for death, a blood clot in a vein, heart failure, and stroke within 30 days. More...
Cases of Ebola in Kampala rise to fourteen *1 Update*
The Monitor newspaper is reporting that Ebola cases in Kampala, Uganda have risen to 14. More...
Coinfection with influenza and RSV creates a new type of virus pathogen
An article in Nature Microbiology describes how a coinfection of influenza A and RSV can create never before seen hybrid virus particles. More...
Preprint: SARS-CoV-2 may have originated as an infectious clone assembled in vitro
A new preprint out today finds that SARS-COV-2 has “a synthetic fingerprint unlikely to have evolved from its close relatives.” More...
WHO: There may be more chains of Ebola transmission *1 Update*
“The Ministry of Health is investigating the most recent eight cases, as initial reports indicate they were not among known contacts.” More...
Singapore: XBB variant more prevalent in those without a previous Covid infection
Singapore’s Health Minister, Ong Ye Kung, has said that he expects the current XBB SARS-CoV-2 wave to peak in mid-November 2022. More...
Chimeric SARS-CoV-2 variant with a mortality rate of 80% *5 Updates*
Boston University scientists undertake a gain of function experiment and create a chimeric recombinant SARS-CoV-2 virus with 80% mortality rate in mice. More...